NR1I2 and depressive symptom measurement: BDNF alters depression by remodeling in the hippocampus; upstream of that are actions of peroxisome proliferator-activated receptor (PPAR)α at PXR to drive increases in mitochondrial activity and, thereby neurosteroidogenesis to allopregnanolone [19].